Adding MMF + tapering CNIs for CNI-associated renal damage

Author：

ISSN： 1173-8324

Source： Inpharma, Vol.1, Iss.1573, 2007-01, pp. : 12-12

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

MMF + reduced-dose CNI easier on the kidneys in liver transplantation

Inpharma, Vol. 1, Iss. 1621, 2008-01 ,pp. : 19-19

Adis International

Access to resources Recommend Favorite

Tacrolimus + sirolimus or MMF in renal transplantation

Inpharma, Vol. 1, Iss. 1428, 2004-01 ,pp. : 15-15

Adis International

Access to resources Recommend Favorite

The pentapeptide PLNPK inhibits systemic lupus erythematosus-associated renal damage

By Lv Jun-qiang Zhang Wen Wang Song Zhao Lin Ma Rui Hu Jin-wei Wang Li-juan Meng Jie Zhou Chun-lei Lin Gang Lu Rong Yao Zhi

Inflammation Research, Vol. 59, Iss. 12, 2010-12 ,pp. : 1081-1089

Springer Publishing Company

Access to resources Recommend Favorite

Switching from azathioprine to mycophenolate mofetil (MMF) improves renal function in paediatric patients with chronic rejection following renal transplantation

Inpharma, Vol. 1, Iss. 1255, 2000-01 ,pp. : 15-15

Adis International

Access to resources Recommend Favorite

A mycophenolate mofetil (MMF)-based regimen produces good allograft and patient survival rates in elderly recipients of cadaveric renal transplants

Inpharma, Vol. 1, Iss. 1500, 2005-01 ,pp. : 13-13

Adis International

Access to resources Recommend Favorite